Medicine Distribution Consents




1158 NEW ZEALAND GAZETTE No. 45

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Hydrocortisone 5 mg, 20 mg Tablets Douglas Pharmaceuticals Limited, Mount Roskill, Auckland
Pantoprazole 40 mg Tablet Byk Gulden Lombergh Chemische Fabrik GmbH., Konstanze, Germany Somac
Dacarbazine 200 mg Powder for injection David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Dacarbazine for Injection
Cefoxitin sodium 1 g, 2 g Powder for injection ACS Dobfar SpA, Tribiano, Milan, Italy Cefoxitin Sodium for Injection

Dated this 3rd day of May 1995.

DAVID SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

go3011

Consent to the Distribution of a New Related Product

Pursuant to section 96 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Stannous fluoride 0.40% w/v Toothpaste Chemplex Liquid, Division of CCL Industries, Etobicoke, Ontario, Canada Oral-B Tooth and Gum Care

Dated this 3rd day of May 1995.

DAVID SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

go3012

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Nedocromil sodium 2% w/v in 2.5 mL, 5 mL, and 10 mL Ophthalmic drops Fisons Laboratories SA, Le Trait, France and Fisons plc., Holmes Chapel, Crewe, Cheshire, England Tilavist Eye Drops
Nafarelin acetate equivalent to 2 mg/mL nafarelin base in 10 mL Nasal spray (metered dose) Syntex Laboratories, Leuville-sur-Orge, Montlhéry, France and Syntex Laboratories Inc., Palo Alto, California, United States of America Synarel
Clarithromycin 250 mg, 500 mg Tablet Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia and Abbott Laboratories Limited, Queensborough, Kent, England and Abbott SpA, Latina, Italy Klacid
Clarithromycin 125 mg/5 mL, 250 mg/5 mL Granules for oral suspension Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia and Abbott Laboratories Limited, Queensborough, Kent, England and Abbott SpA, Latina, Italy Klacid Paediatric Suspension
Felodipine 2.5 mg, 5 mg, 10 mg Tablets, sustained release Astra Pharmaceutical Production AB, Södertälje, Sweden Agon SR
Heparin sodium (tinzaparin sodium) 10 000 anti-Xa IU/mL in 2 mL Injection (multi-dose vials) Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark Logiparin 10 000 anti-Xa IU
Heparin sodium (tinzaparin sodium) 20 000 anti-Xa IU/mL in 5 mL Injection (multi-dose vials) Novo Nordisk A/S, Gentofte, Denmark Logiparin 20 000 anti-Xa IU/mL
Heparin sodium (tinzaparin sodium) 20 000 anti-Xa IU/mL in 1 mL Injection (vial) Novo Nordisk A/S, Gentofte, Denmark Logiparin 20 000 anti-Xa IU/mL
Omeprazole 20 mg Capsule Astra Pharmaceutical Production AB, Södertälje, Sweden Losec
Omeprazole 42.6 mg (equivalent to 40 mg omeprazole) in 10 mL Powder for IV injection (ampoule) plus diluent Astra Pharmaceutical Production AB, Södertälje, Sweden Losec


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1995, No 45


NZLII PDF NZ Gazette 1995, No 45





✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
3 May 1995
Medicine Approval, New Medicines, Medicines Act 1981
  • DAVID SMYTH, Acting Director-General of Health

🏥 Consent to the Distribution of a New Related Product

🏥 Health & Social Welfare
3 May 1995
Medicine Approval, New Related Product, Medicines Act 1981
  • DAVID SMYTH, Acting Director-General of Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
3 May 1995
Medicine Approval, Changed Medicines, Medicines Act 1981
  • DAVID SMYTH, Acting Director-General of Health